Changes of metabolism and mineral density of bone tissue during 6-months therapy with ossin in patients with rheumatoid arthritis
https://doi.org/10.14412/1995-4484-2003-1334
Abstract
Objective. To investigate sodium fluoride (Ossin, "Grunental") influence on bone mineral density and metabolism in pts with rheumatoid arthritis (RA). Material and methods. An 6-month open controlled investigation was carried out. 30 women were included in 2 groups: premenopausal (aged 20-40 years) (PRM) and postmenopausal (aged 50-65 years) (PSM). 2 control groups were formed according to similar pairs method. Each contained 15 women of corresponding activity, disease duration and age. Pts received sodium fluoride 80 mg/day and Calcium Sandos 500 mg/day. Densitometry (QDR 1000 Hologic) and bone metabolism biochemical markers examination were performed at the beginning and at the end of the study. Bone phosphatase (BP) C- terminal propeptid of type I collagen (PICP), osteocalcin in serum, deoxypiridinolin and piridinolin in urine were measured with immunoenzyme assay ("METRA Biosystems”). Results. BP level increased during follow up in both PSM and PRM groups (from 22,9±I4,0 to 37,7+16,0, p<0,00l and from 20,7±8,9 to 26,7±12,6, p<0,05 respectively). There were no changes of other BM. 2,5% increase of lumbar BMD was detected in PRM group (p<0,05 - Fisher exact lest). Control group lumbar BMD decreased by 4,45%. Conclusion. Ossin significantly increased lumbar BMD in premenopausal RA pts.
References
1. <div><p>Гланц С. Биомедицинская статистика. М., "Практика", 1998</p><p>Сметник В.П, Карелина С.Н. Изучение действия препарата оссин при снижении минеральной плотности костной ткани в постменопаузе. Препарат оссин для лечения остеопороза. М., 1998</p><p>Adachi J.D., Bell M.J., Bensen W.G. et al. Fluoride therapy in prevention of rheumatoid arthritis induced bone loss. J. Rheumatol., 1997, 24,12, 2308-2313</p><p>Beat AM., Bloch D.A., Fries J.F. Predictors of fractures in early rheumatoid arthritis. J. Rheumatol., 1991, 18, 80480S</p><p>Charles Y, Pak C. Fluoride and osteoporosis. Proc. Soc. Exp. Biol. Med., 1989, 191, 278-286</p><p>Devogelaer L.P., Boutsen Y., Depresseux G. Comprison of sodium fluoride + calcium with intravenous pamidronate in the therapy of glucocorticoid-induced osteoporosis. 13th European Congress of Rheumatology., 1995, A35, 15</p><p>Guanabens N. Paris A., Monegal A. et al. Ethyldronate ver sus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. Gastroenterology, 1997,113,219-24</p><p>Halverson P.B. Extraarticular manifestations of rheumatoid arthritis. Orthop. Nurs., 1995, 14, 47-50</p><p>Hooyman J.R., Meiton L.J., Nelson A.M. et al. Fractures after rheumatoid arthritis. Arthr. Rheum., 1984, 27, 13531361</p><p>Ingle B.M., Hay S.М., Bottjer H.M. Changes in bone mass and bone turnover following ankle fracture. Osteoporos. Int., 1999,10, 5, 408-15</p><p>Kleerekoper M. Fluoride and the skeleton. Crit. Rev. Clin. Lab. Sc., 1996, 33, 2, 139-61</p><p>Lems W.F., Jacobs J.W., Bijlsma J.W. et al. Is addition of sodium fluoride to cyclical ethydronate beneficial in the treatment of corticosteroid induced osteoporosis? Ann. Rheum. Dis., 1997, 56, 357-63</p><p>Leone N.C., Stevenson C.A. Hilbish T.F. et al. A roentgenologic study of human population exposed to highfluoride domestic water. Am. J. Roentgenol., 1955, 74, 874885</p><p>Pak C.Y., Adams-Huet B., Sakhaee K. et al. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis. J. Bone Miner. Res., 1996,11,160-168</p><p>Riggs B.L. Clinic of fluoride therapy in postmrnopausal osteoporotic women: extended observations and additional analysis. N. Engl. Med., 1990, 322,802-809</p><p>Riggs B.L., Hodgresson S.F., O'Fallon W.M. Effects of fluoride treatment on the fracture rate postmrnopausal women with osteoporosis. N. Engl. Med., 1994, 9,265-275</p><p>Rizzolo R., Chevalley T. Sodium-monofluorophosphate increase vertebral bone mineral density in patients with cor- ticoid-induced osteoporosis. Osteoporos. Int., 1995,5,39-46</p><p>SpectorT.D., Hall G.M., McCloskey E.V., Kanis J.A. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ., 1993, 306, 558</p><p>Verstraeten A., Degueker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patiens with rheumatoid arthritis: effect of low dose corticosteroids. Ann. Rheum. Dis., 1986, 45, 852-857</p></div><br />
Review
For citations:
Kupavtseva E.A., Klyukvina N.G., Balabanova R.M., Lebedeva T.V., Smirnov A.V. Changes of metabolism and mineral density of bone tissue during 6-months therapy with ossin in patients with rheumatoid arthritis. Rheumatology Science and Practice. 2003;41(4):53-57. (In Russ.) https://doi.org/10.14412/1995-4484-2003-1334
Views:
776
Email this article 